Literature DB >> 21638513

Outcomes after thyroidectomy and parathyroidectomy.

Prateek K Gupta1, Russell B Smith, Himani Gupta, R Armour Forse, Xiang Fang, William M Lydiatt.   

Abstract

BACKGROUND: Previous reports on postoperative outcomes following thyroid and parathyroid surgery are limited by relatively small sample size. We report 30-day outcomes following thyroid and parathyroid surgery and analyze factors affecting length of stay (LOS) and postoperative adverse events (AEs).
METHODS: The multicenter, prospective, National Surgical Quality Improvement Program (NSQIP) datasets (2007/2008) were used. Multivariable logistic regression and analysis of covariance (ANCOVA) were performed.
RESULTS: Patients undergoing thyroidectomy, parathyroidectomy, or both were identified (n = 13,380, 6154, 1535, respectively). Thirty-day mortality was 0.08%, 0.16%, and 0.2%, respectively; 30-day morbidity was 3.50%, 3.02%, and 4.04%, respectively. Mean LOS values were 1.1 ± 1.4, 1.1 ± 2.1, and 1.4 ± 3.1 days, respectively. Congestive heart failure, dependent functional status, dialysis dependence, and chronic corticosteroid use were significantly associated with increased LOS and postoperative AE.
CONCLUSIONS: Morbidity and mortality rates following thyroid and parathyroid surgery are low. These data could be used by third-party interests, and surgeons should be aware of them to ensure their outcomes are in the national norm.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21638513     DOI: 10.1002/hed.21757

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  11 in total

1.  Mortality after thyroid surgery, insignificant or still an issue?

Authors:  Joaquín Gómez-Ramírez; Antonio Sitges-Serra; Pablo Moreno-Llorente; Antonio Ríos Zambudio; Joaquín Ortega-Serrano; María Teresa Gutiérrez Rodríguez; Jesús Villar del Moral
Journal:  Langenbecks Arch Surg       Date:  2015-04-23       Impact factor: 3.445

2.  The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism.

Authors:  Kerstin M Ivarsson; Shahriar Akaberi; Elin Isaksson; Eva Reihnér; Rebecca Rylance; Karl-Göran Prütz; Naomi Clyne; Martin Almquist
Journal:  Nephrol Dial Transplant       Date:  2015-09-15       Impact factor: 5.992

Review 3.  Calcimimetics versus parathyroidectomy: What is preferable?

Authors:  M Rroji; G Spasovski
Journal:  Int Urol Nephrol       Date:  2018-03-12       Impact factor: 2.370

Review 4.  Surgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons.

Authors:  Kerstin Lorenz; Detlef K Bartsch; Juan J Sancho; Sebastien Guigard; Frederic Triponez
Journal:  Langenbecks Arch Surg       Date:  2015-10-02       Impact factor: 3.445

5.  Annual financial impact of well-differentiated thyroid cancer care in the United States.

Authors:  Carrie C Lubitz; Chung Y Kong; Pamela M McMahon; Gilbert H Daniels; Yufei Chen; Konstantinos P Economopoulos; G Scott Gazelle; Milton C Weinstein
Journal:  Cancer       Date:  2014-01-30       Impact factor: 6.860

6.  Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis.

Authors:  Areef Ishani; Jiannong Liu; James B Wetmore; Kimberly A Lowe; Thy Do; Brian D Bradbury; Geoffrey A Block; Allan J Collins
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-16       Impact factor: 8.237

7.  Clinical and Healthcare Utilization Outcomes of Parathyroidectomy in CKD and Dialysis Patients.

Authors:  Scott A Jones; Katharine Hegerty; Carla Scuderi; Jessica Eglington; Ben Green; Andrew Mallett
Journal:  Kidney Int Rep       Date:  2020-05-07

8.  A Prospective Randomized Comparison of Postoperative Pain and Complications after Thyroidectomy under Different Anesthetic Techniques: Volatile Anesthesia versus Total Intravenous Anesthesia.

Authors:  Jun-Young Jo; Yeon Ju Kim; Seong-Soo Choi; Jihoon Park; Han Park; Kyung-Don Hahm
Journal:  Pain Res Manag       Date:  2021-02-02       Impact factor: 3.037

9.  Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism.

Authors:  Willemijn Y van der Plas; Anton F Engelsman; Akin Özyilmaz; Anouk N van der Horst-Schrivers; Kornelis Meijer; Gooitzen M van Dam; Robert A Pol; Martin H de Borst; Schelto Kruijff
Journal:  Ann Surg Oncol       Date:  2016-07-26       Impact factor: 5.344

10.  Clinical and Economical Outcomes Associated with Parathyroidectomy: A 5-Year Population-Based Study in a Middle-Income Country with Universal Health Coverage.

Authors:  Kateir Contreras; Romar Baquero; Giancarlo Buitrago
Journal:  Int J Nephrol       Date:  2020-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.